Comment: bacterial endocarditis recommendations.
作者信息
Jones M
出版信息
Ann Pharmacother. 1992 May;26(5):716. doi: 10.1177/106002809202600524.
PMID:1591439
Abstract
摘要
相似文献
1
Comment: bacterial endocarditis recommendations.评论：细菌性心内膜炎的建议。
Ann Pharmacother. 1992 May;26(5):716. doi: 10.1177/106002809202600524.
2
Prevention of bacterial endocarditis.细菌性心内膜炎的预防
JAMA. 1991 Apr 3;265(13):1686-8.
3
Erythromycin dosing error in bacterial endocarditis.
J Am Dent Assoc. 1991 Nov;122(11):10, 12. doi: 10.14219/jada.archive.1991.0308.
4
More on endocarditis guidelines.更多关于心内膜炎指南的内容。
N Y State Dent J. 1990 Mar;56(3):8.
5
Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
J Clin Pharmacol. 1985 Jan-Feb;25(1):36-42. doi: 10.1002/j.1552-4604.1985.tb02798.x.
6
Endocarditis prophylaxis.
J Am Dent Assoc. 1988 Feb;116(2):154. doi: 10.14219/jada.archive.1988.0346.
7
The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
J Antimicrob Chemother. 1984 Aug;14(2):157-63. doi: 10.1093/jac/14.2.157.
8
Medication for endocarditis prevention.用于心内膜炎预防的药物。
J Am Dent Assoc. 1989 Feb;118(2):144. doi: 10.14219/jada.archive.1989.0228.
9
Mitral valve prolapse: a review of the syndrome with emphasis on current antibiotic prophylaxis.
J Can Dent Assoc. 1991 Apr;57(4):321-5.
10
Antibiotic prophylaxis for infective endocarditis. FDI Commission Working Group.
Int Dent J. 1994 Jun;44(3):215-22.
Zotero 插件